Tag: post-approval drug monitoring
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Vasculitis: Understanding Autoimmune Inflammation of Blood Vessels
Jan, 18 2026
False Advertising in Generics: Legal Risks and Rules You Can't Ignore
Nov, 24 2025
How to Choose the Right Generic Medication When Multiple Options Are Available
Dec, 3 2025
Hydration Plans to Protect Kidneys from Nephrotoxic Medications
Nov, 21 2025
The connection between pharyngeal mucous membranes and bad breath
Sep, 4 2023